Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Bnai Zion Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bnai Zion Medical Center
ClinicalTrials.gov Identifier:
NCT00408759
First received: December 6, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted

December 6, 2006
December 6, 2006
November 2006
Not Provided
  • salivaa volume
  • quality of life related to salivation
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.

hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.

10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Interventional
Phase 2
Allocation: Non-Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Xerostomia
Behavioral: hypnosis
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
10
December 2006
Not Provided

Inclusion Criteria:

  • radiotherapy for head and neck cancer
  • xerostomia

Exclusion Criteria:

  • psychiatric illness (present or past)
Both
18 Years and older
No
Contact: elad schiff 972482654767 eschiff@email.arizona.edu
Contact: gorge mogilner 97248359359 eschiff@bezeqint.net
Israel
 
NCT00408759
eschiff
Not Provided
Not Provided
Bnai Zion Medical Center
Not Provided
Principal Investigator: Elad Schiff Bnai Zion MC
Bnai Zion Medical Center
December 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP